Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01952 EVEREST MED
RT Nominal up74.500 +1.800 (+2.476%)
Ranking Overview
Buy
Ranking based on 3 research report(s)
Average Ranking 2.33
0
2
1
0
0
Previous Financial Performance
Financial Year 12/2024 EPS -324.00 RMB (cts)
Net Profit -1,041.38 RMB (MIL) DPS 0.00 RMB (cts)
Consolidation Estimation
Financial Year Profit / (Loss)
(RMB (MIL))
EPS/
((LPS)(RMB (cts))
DPS
(RMB (cts))
Net Asset Value per Share
(RMB)
Highest
(RMB (MIL))
Lowest
(RMB (MIL))
2025-267.00-82.000---37.00-482.00
2026165.0051.400--239.0012.00
2027674.00208.500--743.00605.00
Profit Estimation
Profit Estimation Profit / (Loss)
(RMB (MIL))
EPS*/
(LPS) (RMB (cts))
DPS *
(RMB (cts))
Broker Ranking Target Price*
(HKD)
Update Date
2025-482.00-147.00--CICCOutPerform80.00 01/07/2025
2025-267.00-82.00--BOCOMBuy72.50 02/07/2025
2025-37.00-11.50--BANK OF AMERICANeutral55.80 27/03/2025
 
202612.004.00--CICC----01/07/2025
2026239.0074.00--BOCOM----02/07/2025
2026165.0051.40--BANK OF AMERICA----27/03/2025
 
2027743.00229.00--BOCOM----02/07/2025
2027605.00188.00--BANK OF AMERICA----27/03/2025
Remarks:  Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa.
  *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue
  Real time quote last updated: 21/07/2025 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service